🇮🇹 Italy Country × Condition
alzheimer disease Clinical Trials in Italy
Active clinical trials for alzheimer disease with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇮🇹 Italy
Active Trials in Italy (4)
NCT06668610
Recruiting
A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
Enrollment
50 pts
Country
🇮🇹 Italy
University of Campania Luigi Vanvit...
View Trial → NCT06702124 Phase 3
Recruiting
A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
Enrollment
348 pts
Country
🇮🇹 Italy
I.R.C.C.S. Fondazione Santa Lucia
View Trial → NCT07066137
Recruiting
Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices
Enrollment
150 pts
Country
🇮🇹 Italy
IRCCS Centro Neurolesi Bonino Pulej...
View Trial → NCT07717567
Recruiting
Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression
Enrollment
2,000 pts
Country
🇮🇹 Italy
IRCCS San Raffaele
View Trial → Frequently Asked Questions
How many alzheimer disease clinical trials are active in Italy?
There are currently 4 active clinical trials for alzheimer disease with sites in Italy, of which 4 are actively recruiting patients.
How can I join a alzheimer disease clinical trial in Italy?
To join a alzheimer disease clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are alzheimer disease trials in Italy?
Active alzheimer disease trials in Italy span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology